Stay updated with breaking news from Solid Tumor Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Established clinician researcher will focus on novel treatments and clinical trials for difficult-to-treat childhood cancers.
Established clinician researcher will focus on novel treatments and clinical trials for difficult-to-treat childhood cancers.
Provides fiscal year 2025 revenue guidance of $12 - $16 millionUS pilot trial of LungFit® PRO to treat viral community acquired pneumonia (VCAP) u...
22.06.2023 - Successfully completed phase 1 of U.S. commercial launch, with multiple hospitals contracted, and have initiated phase 2 of launch for LungFit PH for the treatment of term and near-term neonates with hypoxic respiratory failure Presented positive ...
Rhabdomyosarcoma is a type of soft tissue cancer. Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence.